Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 10;16(5):155.
doi: 10.3390/md16050155.

The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α- N-Acetylgalactosaminidase of Human Colon Carcinoma Cells

Affiliations

The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α- N-Acetylgalactosaminidase of Human Colon Carcinoma Cells

Irina Bakunina et al. Mar Drugs. .

Abstract

α-N-acetylgalactosaminidase (EC 3.2.1.49) (alpha-NaGalase) catalyzes the hydrolysis of N-acetamido-2-deoxy-α-d-galactoside residues from non-reducing ends of various complex carbohydrates and glycoconjugates. It is known that human cancer cells express an alpha-NaGalase, which accumulates in the blood plasma of patients. The enzyme deglycosylates the Gc protein-derived macrophage activating factor (GcMAF) and inhibits macrophage activity acting as an immunosuppressor. The high specific activity 0.033 ± 0.002 μmol mg−1 min−1 of the enzyme was found in human colon carcinoma cells DLD-1. The alpha-NaGalase of DLD-1 cells was isolated and biochemical characterized. The enzyme exhibits maximum activity at pH 5.2 and temperature 55 °C. The Km is 2.15 mM, Vmax⁻0.021 μmol min−1 mL−1, kcat⁻1.55 min−1 and kcat/Km⁻0.72 min−1 mM−1 at 37 °C, pH 5.2. The effects of fucoidan from the brown alga Fucus evanescence on the activity of alpha-NaGalase in human colon carcinoma DLD-1 cells and on the biosynthesis of this enzyme were investigated. It was shown that fucoidan did not inhibit free alpha-NaGalase, however, it reduced the expression of the enzyme in the DLD-1 cells at IC50 73 ± 4 μg mL−1.

Keywords: DLD-1; Fucus evanescence; alpha-NaGalase; brown alga; colon carcinoma cells; fucoidan; macrophage activating factor; α-N-acetylgalactosaminidase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Purification of alpha-NaGalase from lysate of cancer cells DLD-1: (А) Scheme of enzyme purification; (B) 12% SDS-PAGE of purified alpha-NaGalase (1), molecular mass markers (2).
Figure 2
Figure 2
pH-Dependence of alpha-NaGalase activity of DLD-1 human colon carcinoma cells, 0.05 M sodium citrate buffer, 37 °C.
Figure 3
Figure 3
Effect of temperature on the alpha-NaGalase activity of DLD-1 human colon carcinoma cells, 0.05 M sodium citrate buffer, pH 5.0.
Figure 4
Figure 4
Temperature stability of alpha-NaGalase of DLD-1 human colon carcinoma cells at different exposition time; 1 and 6 correspond to 100% activity and 50% activity of the enzyme, respectively, 0.05 M sodium citrate buffer, pH 5.0; graph 2, 3, 4, 5 correspond to 15, 30, 45 and 60 min of exposition, respectively.
Figure 5
Figure 5
Dependence of p-Nitrophenyl-N-acetyl-α-d-galactosaminide hydrolysis rate on the concentration catalyzing by alpha-NaGalase of DLD-1 cancer cells in double reciprocal Lineweaver–Burk coordinates, 0.05 M sodium citrate buffer, pH 5.0, 37 °C. The inset table shows the results of liner fitting with using the computer program “Orijin 8.0”.
Figure 6
Figure 6
Effect of NaCl on the alpha-NaGalase of DLD-1 human colon carcinoma cells.
Figure 7
Figure 7
Effect of fucoidan from brown alga Fucus evanescence on the production of alpha-NaGalase in colon cancer cells DLD-1 and on the activity of the free alpha-NaGalase, 0.05 M sodium citrate buffer, pH 5.0, the enzyme with fucoidan was incubated for 30 min at 20 °C. Data are shown as means ± standard deviation (SD) of values from three independent experiments. The asterisk (*) indicates a significant decrease in activity of cellular alpha-NaGalase of DLD-1 cells treated with fucoidan compared with the non-treated cells (** p < 0.01, *** p < 0.001.).

Similar articles

Cited by

References

    1. Santos-Pereira J.M., Muñoz-Galván S. Biomarkers of colorectal cancer: A genome-wide perspective. Cancer Transl. Med. 2016;2:182–188.
    1. Clausen H., Hakomori S.-I. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989;56:1–20. doi: 10.1111/j.1423-0410.1989.tb03040.x. - DOI - PubMed
    1. Wu A.M., Wu J.H., Chen Y.Y., Tsai M.S., Herp A. Forssman pentasaccharide and polyvalent Galβ1→4GlcNAc as major ligands with affinity for Caragana arborescens agglutinin. FEBS Lett. 1999;463:223–230. doi: 10.1016/S0014-5793(99)01629-4. - DOI - PubMed
    1. Nakajima H., Kurosaka A., Fujisawa A., Kawasaki T., Matsuyana M., Nagayo T., Yamashina I. Isolation and characterization of a glycoprotein from a human rectal adenocarcinoma. J. Biochem. 1983;93:651–659. doi: 10.1093/oxfordjournals.jbchem.a134221. - DOI - PubMed
    1. Wu A.M. Carbohydrate structural units in glycosphingolipids as receptors for Gal and GalNAc reactive lectins. Neurochem. Res. 2002;27:593–600. doi: 10.1023/A:1020263730943. - DOI - PubMed

Substances